Histogenics (HSGX) Misses Q3 EPS by 21c
Tweet
Share
E-mailGet Alerts HSGX Hot Sheet
Join SI Premium – FREE
Histogenics (NASDAQ: HSGX) reported Q3 EPS of ($0.70), $0.21 worse than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Histogenics (HSGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Philip Morris (PM) beats Q1 earnings, revenue estimates; issues upbeat guidance
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
